Yong-Woon Kim

Yong-Woon Kim

Auto-generated profile, based on publicly available information

Yong-Woon Kim

Department of Physiology, Yeungnam University College of Medicine, Daegu, Korea

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Diabetes
Verified
Journal Article
Closed access
PDF file
YKYong-Woon Kim
Yong-Woon Kim
JKJong-Yeon Kim
Jong-Yeon Kim
YPYong-Hoon Park
Yong-Hoon Park
SPSo-Young Park
So-Young Park
KWKyu-Chang Won
Kyu-Chang Won
KMKi-Hak Moon
Ki-Hak Moon
To evaluate whether metformin enhances leptin sensitivity, we measured leptin sensitivity after 4 weeks of metformin treatment (300 mg/kg daily) in both standard chow and high-fat–fed obese rats. Anorexic and fat-losing responses after intracerebroventricular leptin infusion for 7 days (15 μg daily per rat) in standard chow rats were enhanced by metformin treatment, and these responses to leptin were attenuated in high-fat–fed obese rats compared with age-matched standard chow rats. However, these responses to leptin were corrected by metformin treatment in high-fat–fed obese rats. Moreover, serum concentrations of leptin and insulin were decreased dramatically by leptin in metformin-treated standard chow and high-fat–fed obese rats. The hypothalamic phosphorylated AMP-activated protein kinase level was decreased by lower leptin dose in metformin-treated rats than in untreated rats. In an acute study, metformin treatment also increased the anorexic effect of leptin (5 μg), and this was accompanied by an increased level of phosphorylated signal transducer and activator of transcription 3 in the hypothalamus. These results suggest that metformin enhances leptin sensitivity and corrects leptin resistance in high-fat–fed obese rats and that a combination therapy including metformin and leptin would be helpful in the treatment of obesity.

1 January 2019 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
KMKi Hak Moon
Ki Hak Moon
SPSo Young Park
So Young Park
YKYong Woon Kim
Yong Woon Kim
Moon KH, et al. World J Mens Health. 2018 Jan;36:e24. https://doi.org/10.5534/wjmh.180026

31 January 2023 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
DSDae-Kyu Song
Dae-Kyu Song
YKYong-Woon Kim
Yong-Woon Kim
Caloric restriction is a popular approach to treat obesity and its associated chronic illnesses but is difficult to maintain for a long time. Intermittent fasting is an alternative and easily applicable dietary intervention for caloric restriction. Moreover, intermittent fasting has beneficial effects equivalent to those of caloric restriction in terms of body weight control, improvements in glucose homeostasis and lipid profiles, and anti-inflammatory effects. In this review, the beneficial effects of intermittent fasting are discussed.

1 January 2012 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
CLChang Koo Lee
Chang Koo Lee
YCYoon Jung Choi
Yoon Jung Choi
SPSo Young Park
So Young Park
JKJong Yeon Kim
Jong Yeon Kim
KWKyu Chang Won
Kyu Chang Won
YKYong Woon Kim
Yong Woon Kim
Metformin, an oral biguanide insulin-sensitizing agent, is well known to decrease appetite. Although there is evidence that metformin could affect the brain directly, the exact mechanism is not yet known. To evaluate whether metformin induces anorexia via the hypothalamus, various concentrations of metformin were injected into the lateral ventricle of rats through a chronically implanted catheter and food intake was measured for 24 hours. The hypothalamic neuropeptides associated with regulation of food intake were also analyzed following 1 hour of intracerebroventricular (ICV) injections of metformin. An ICV injection of metformin decreased food intake in a dose-dependent manner in unrestrained conscious rats. Hypothalamic phosphorylated AMP-activated protein kinase (pAMPK) increased by 3 µg with metformin treatment, but there was no further increase in pAMPK with increases in metformin dosage. The hypothalamic phosphorylated signal transducer and activator of transcription 3 (pSTAT3) increased by 3 µg with metformin treatment, but, there was no further increase in pSTAT3 level following increases of metformin dosage. Hypothalamic proopiomelanocortin was elevated with metformin treatment, while neuropeptide Y was not significantly changed. Our results suggest that metformin induces anorexia via direct action in the hypothalamus and the increase in pSTAT3, at least in part, is involved in the process. However, hypothalamic pAMPK appears not to contribute to metformin-induced appetite reduction in normal rats. Further studies exploring new pathways connecting metformin and feeding regulation are needed.

1 January 2011 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
YPYeul Bum Park
Yeul Bum Park
YCYun Jung Choi
Yun Jung Choi
SPSo Young Park
So Young Park
JKJong Yeon Kim
Jong Yeon Kim
SKSeong Ho Kim
Seong Ho Kim
YKYong Woon Kim
Yong Woon Kim
Park YB, et al. Diabetes Metab J. 2011 Jun;35(3):219-225. https://doi.org/10.4093/dmj.2011.35.3.219

4 December 2019 in Cells
Verified
Journal Article
Open access
PDF file
ELEun Ju Lee
Eun Ju Lee
SSSibhghatulla Shaikh
Sibhghatulla Shaikh
DCDukhwan Choi
Dukhwan Choi
Khurshid AhmadKhurshid Ahmad
Khurshid Ahmad
MBMohammad Hassan Baig
Mohammad Hassan Baig
ICInho Choi
Inho Choi
Skeletal muscle, the largest part of the total body mass, influences energy and protein metabolism as well as maintaining homeostasis. Herein, we demonstrate that during murine muscle satellite cell and myoblast differentiation, transthyretin (TTR) can exocytose via exosomes and enter cells as TTR- thyroxine (T4) complex, which consecutively induces the intracellular triiodothyronine (T3) level, followed by T3 secretion out of the cell through the exosomes. The decrease in T3 with the TTR level in 26-week-old mouse muscle, compared to that in 16-week-old muscle, suggests an association of TTR with old muscle. Subsequent studies, including microarray analysis, demonstrated that T3-regulated genes, such as FNDC5 (Fibronectin type III domain containing 5, irisin) and RXRγ (Retinoid X receptor gamma), are influenced by TTR knockdown, implying that thyroid hormones and TTR coordinate with each other with respect to muscle growth and development. These results suggest that, in addition to utilizing T4, skeletal muscle also distributes generated T3 to other tissues and has a vital role in sensing the intracellular T4 level. Furthermore, the results of TTR function with T4 in differentiation will be highly useful in the strategic development of novel therapeutics related to muscle homeostasis and regeneration.